References

1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. Abraham, C., and J. H. Cho. 2006. Functional consequences of NOD2 (CARD15) mutations. Inflamm. Bowel Dis. 12:641-6650. Anderson, J. L., et al. 2007. Mycobacterium avium subsp. paratuberculosis in scavenging mammals in Wisconsin. J. Wildl. Dis. 43:302-308. Barnes, P. J., and M. Karin. 1997. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066-1071. Boudeau, J., A. L. Glasser, E. Masseret, B. Joly, and A. Darfeuille-Michaud. 1999. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect. Immun. 67:4499-4509. Brant, S. R. 2011. Update on the heritability of inflammatory bowel disease: the importance of twin studies. Inflamm. Bowel Dis. 17:1-5. Bull, T. J., et al. 2003. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J. Clin. Microbiol. 41:2915-2923. Bylund, J., D. Goldblatt, and D. P. Speert. 2005. Chronic granulomatous disease: From genetic defect to clinical presentation. Adv. Exp. Med. Biol. 568:67-87. Cadwell, K., et al. 2008. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456:259-263. Chacon, O., L. E. Bermudez, and R. G. Barletta. 2004. Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu. Rev. Microbiol. 58:3f-363. Chassaing, B., and A. Darfeuille-Michaud. 2011. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140:1720-1728. Cho, J. H. 2008. The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. Immunol. 8:458-466. Cho, J. H., and S. R. Brant. 2011. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 140:1704-1712. Cooney, R., et al. 2010. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 16:90-97. Coulombe, F., et al. 2009. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. J. Exp. Med. 206:1709-1716. Cucino, C., and A. Sonnenberg. 2001. Occupational mortality from inflammatory bowel disease in the United States 1991-1996. Am. J. Gastroenterol. 96:1101-1105. Darfeuille-Michaud, A., et al. 2004. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127:412-421. Divangahi, M., et al. 2008. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J. Immunol. 181:71577165. Felley, C. 2006. Les apports de NOD2/CARD15 dans la prise en charge de la maladie de Crohn. Hépato-Gastro 13:429-432. Gersemann, M., J. Wehkamp, and E. Stange. 30 Dec 2011. Innate immune dysfunction in inflammatory bowel disease. J. Intern. Med. doi: 10.1111/j.1365-2796.2011.02515.x Girardin, S. E., et al. 2003. NOD2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Chem. Biol. 278:8869-8872. Glasser, A. L., et al. 2001. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect. Immun. 69:5529-5537.

22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45. 46.

Gutierrez, M. G., et al. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119:753-766. Hedl, M., J. Li, J. H. Cho, and C. Abraham. 2007. Chronic stimulation of NOD2 mediates tolerance to bacterial products. Proc. Natl. Acad. Sci. U.S.A. 104:19440-19445. Hruz, P., Eckmann, L. 2010. Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn’s disease. Swiss Med. Wkly. 140: 13135-13142. Inohara, N., et al. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Chem. Biol. 278:5509-5512. Jeyanathan, M., et al. 2007. Visualization of Mycobacterium avium in Crohn's tissue by oilimmersion microscopy. Microbes Infect. 9:1567-1573. Kaser, A., and R. S. Blumberg. 2011. Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease. Gastroenterology 140:1738-1747. Kotlowski, R., C. N. Bernstein, S. Sepehri, and D. O. Krause. 2007. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 56:669-675. Lalande, J. 2011. Masters thesis. McGill University, Montreal, Quebec, Canada. Le Bourhis, L., S. Benko, and S. E. Girardin. 2007. NOD1 and NOD2 in innate immunity and human inflammatory disorders. Biochem. Soc. Trans. 35:1479-1484. Mach, T. 2006. Clinical usefulness of probiotics in inflammatory bowel diseases. J. Physiol. Pharmacol. 57:23-33. Man, S. M., N. O. Kaakoush, and H. M. Mitchell. 2011. The role of bacteria and patternrecognition receptors in Crohn's disease. Nat. Rev. Gastroenterol. Hepatol. 8:152-168. McCarroll, S. A., et al. 2008. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Genet. 40:1107-1112. Mow, W. S., et al. 2004. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 126:414-424. Nandivada, P., V. Poylin, D. Nagle. 2012. Advances in the surgical management of inflammatory bowel disease. Curr. Opin. Gastroenterol. 1:47-51. Nos, P., and E. Domenech. 2011. Management of Crohn's disease in smokers: is an alternative approach necessary? World J. Gastroenterol. 17:3567-3574. Ogura, Y., et al. 2001. NOD2, a NOD1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276:4812-4818. Ogura, Y., et al. 2003. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52:1591-1597. Over, K., P. G. Crandall, C. A. O'Bryan, and S. C. Ricke. 2011. Current perspectives on Mycobacterium avium subsp. paratuberculosis, Johne's disease, and Crohn's disease: a review. Crit. Rev. Microbiol. 37:141-156. Pandey, A. K., et al. 2009. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog. 5:e1000500. Podolsky, D. K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347:417-429. Salucci, V., et al. 2008. Monocyte-derived dendritic cells from Crohn patients show differential NOD2/CARD15-dependent immune responses to bacteria. Inflamm. Bowel Dis. 14:812-818. Schmid, D., M. Pypaert, and C. Munz. 2007. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 26:79-92. Schwartz, D., et al. 2000. Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients. Clin. Microbiol. Infect. 6:303307. Shanahan, F. 2002. Crohn's disease. Lancet 359:62-69. Singh, S. B., A. S. Davis, G. A. Taylor, and V. Deretic. 2006. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313:1438-1441.

47. 48. 49. 50. 51. 52. 53. 54.

Strober, W., and I. J. Fuss. 2011. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140:1756-1767. Strober, W., A. Kitani, I. Fuss, N. Asano, and T. Watanabe. 2008. The molecular basis of NOD2 susceptibility mutations in Crohn's disease. Mucosal immunol. 1 (Suppl 1):S5-9. Swidsinski, A., et al. 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122:44-54. Tada, H., S. Aiba, K. Shibata, T. Ohteki, and H. Takada. 2005. Synergistic effect of NOD1 and NOD2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect. Immun. 73:7967-7976. Travassos, L. H., et al. 2010. NOD1 and NOD2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 11:55-67. Van Deventer, S. J. 1997. Tumour necrosis factor and Crohn's disease. Gut 40:443-448. Waddell, L. A., et al. 2008. The zoonotic potential of Mycobacterium avium spp. paratuberculosis: a systematic review. Can. J. Public Health 99:145-155. Yamamoto, S., and X. Ma. 2009. Role of NOD2 in the development of Crohn's disease. Microbes Infect. 11:912-918.